KR20210105916A - 우루소데옥시콜산을 함유하는 노시의 치료 또는 예방제 - Google Patents
우루소데옥시콜산을 함유하는 노시의 치료 또는 예방제 Download PDFInfo
- Publication number
- KR20210105916A KR20210105916A KR1020217019942A KR20217019942A KR20210105916A KR 20210105916 A KR20210105916 A KR 20210105916A KR 1020217019942 A KR1020217019942 A KR 1020217019942A KR 20217019942 A KR20217019942 A KR 20217019942A KR 20210105916 A KR20210105916 A KR 20210105916A
- Authority
- KR
- South Korea
- Prior art keywords
- ursodeoxycholic acid
- ester
- acid
- lens
- ursodeoxycholic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018236717 | 2018-12-18 | ||
| JPJP-P-2018-236717 | 2018-12-18 | ||
| PCT/JP2019/049352 WO2020129964A1 (ja) | 2018-12-18 | 2019-12-17 | ウルソデオキシコール酸を含有する老視の治療または予防剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20210105916A true KR20210105916A (ko) | 2021-08-27 |
Family
ID=71100366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217019942A Ceased KR20210105916A (ko) | 2018-12-18 | 2019-12-17 | 우루소데옥시콜산을 함유하는 노시의 치료 또는 예방제 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20220072012A1 (enExample) |
| EP (1) | EP3900728A4 (enExample) |
| JP (2) | JP6771698B1 (enExample) |
| KR (1) | KR20210105916A (enExample) |
| CN (1) | CN113164499A (enExample) |
| AU (1) | AU2019407391A1 (enExample) |
| BR (1) | BR112021011653A2 (enExample) |
| CA (1) | CA3123370A1 (enExample) |
| EA (1) | EA202191684A1 (enExample) |
| IL (1) | IL284004A (enExample) |
| MX (1) | MX2021007161A (enExample) |
| MY (1) | MY203280A (enExample) |
| PH (1) | PH12021551412A1 (enExample) |
| SG (1) | SG11202106216SA (enExample) |
| TW (1) | TW202038966A (enExample) |
| WO (1) | WO2020129964A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6771698B1 (ja) | 2018-12-18 | 2020-10-21 | 参天製薬株式会社 | ウルソデオキシコール酸を含有する老視の治療または予防剤 |
| CA3210908A1 (en) | 2021-02-15 | 2022-08-18 | Santen Pharmaceutical Co., Ltd. | Water-based pharmaceutical composition containing ursodeoxycholic acid or salt thereof |
| US20220349486A1 (en) * | 2021-04-29 | 2022-11-03 | Baker Hughes Oilfield Operations Llc | Modulating pilot valve adapter |
| TW202412751A (zh) * | 2022-08-09 | 2024-04-01 | 日商參天製藥股份有限公司 | 含有udca或其鹽之水性醫藥組合物 |
| CN116211804B (zh) * | 2023-05-09 | 2025-09-05 | 北京汇诚益健医药科技有限责任公司 | 熊去氧胆酸脂质组合物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2442647B1 (en) | 2009-06-15 | 2016-03-16 | Encore Health LLC | Dithiol compounds, derivatives, and uses therefor |
| CN102178784B (zh) * | 2011-04-20 | 2013-06-12 | 威海康博尔生物药业有限公司 | 一种用于缓解视疲劳的药物组合物 |
| US9724357B2 (en) * | 2011-08-15 | 2017-08-08 | Massachusetts Eye & Ear Infirmary | Methods for preserving photoreceptor cell viability following retinal detachment |
| CN104083381A (zh) * | 2014-07-29 | 2014-10-08 | 上海中医药大学 | 熊去氧胆酸的医药用途 |
| WO2016029197A1 (en) * | 2014-08-22 | 2016-02-25 | Kang Zhang | Compositions and methods to treat and/or prevent vision disorders of the lens of the eye |
| CN109481392B (zh) * | 2015-09-02 | 2021-12-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种用于预防和治疗白内障的眼用制剂及其制备方法 |
| WO2018147685A1 (ko) * | 2017-02-09 | 2018-08-16 | 주식회사 유스바이오팜 | 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물 |
| KR102252450B1 (ko) * | 2017-02-09 | 2021-05-14 | 주식회사 아미코젠파마 | 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물 |
| WO2018164113A1 (ja) * | 2017-03-06 | 2018-09-13 | 学校法人 慶應義塾 | マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤 |
| JP6771698B1 (ja) * | 2018-12-18 | 2020-10-21 | 参天製薬株式会社 | ウルソデオキシコール酸を含有する老視の治療または予防剤 |
-
2019
- 2019-12-17 JP JP2020520162A patent/JP6771698B1/ja not_active Expired - Fee Related
- 2019-12-17 EP EP19899899.9A patent/EP3900728A4/en not_active Withdrawn
- 2019-12-17 MX MX2021007161A patent/MX2021007161A/es unknown
- 2019-12-17 PH PH1/2021/551412A patent/PH12021551412A1/en unknown
- 2019-12-17 MY MYPI2021003222A patent/MY203280A/en unknown
- 2019-12-17 KR KR1020217019942A patent/KR20210105916A/ko not_active Ceased
- 2019-12-17 US US17/414,285 patent/US20220072012A1/en not_active Abandoned
- 2019-12-17 EA EA202191684A patent/EA202191684A1/ru unknown
- 2019-12-17 SG SG11202106216SA patent/SG11202106216SA/en unknown
- 2019-12-17 TW TW108146291A patent/TW202038966A/zh unknown
- 2019-12-17 AU AU2019407391A patent/AU2019407391A1/en not_active Abandoned
- 2019-12-17 CA CA3123370A patent/CA3123370A1/en active Pending
- 2019-12-17 WO PCT/JP2019/049352 patent/WO2020129964A1/ja not_active Ceased
- 2019-12-17 BR BR112021011653-2A patent/BR112021011653A2/pt not_active Application Discontinuation
- 2019-12-17 CN CN201980081377.5A patent/CN113164499A/zh active Pending
-
2020
- 2020-09-29 JP JP2020163766A patent/JP2021006548A/ja active Pending
-
2021
- 2021-06-15 IL IL284004A patent/IL284004A/en unknown
- 2021-12-09 US US17/546,895 patent/US11419880B2/en active Active
-
2022
- 2022-08-02 US US17/816,812 patent/US20230040386A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112021011653A2 (pt) | 2021-09-08 |
| JP6771698B1 (ja) | 2020-10-21 |
| SG11202106216SA (en) | 2021-07-29 |
| EP3900728A1 (en) | 2021-10-27 |
| EA202191684A1 (ru) | 2021-09-01 |
| JP2021006548A (ja) | 2021-01-21 |
| US20220096497A1 (en) | 2022-03-31 |
| AU2019407391A1 (en) | 2021-07-01 |
| WO2020129964A1 (ja) | 2020-06-25 |
| US20230040386A1 (en) | 2023-02-09 |
| US20220072012A1 (en) | 2022-03-10 |
| JPWO2020129964A1 (ja) | 2021-02-15 |
| CN113164499A (zh) | 2021-07-23 |
| IL284004A (en) | 2021-08-31 |
| EP3900728A4 (en) | 2022-08-17 |
| CA3123370A1 (en) | 2020-06-25 |
| TW202038966A (zh) | 2020-11-01 |
| PH12021551412A1 (en) | 2022-05-02 |
| MX2021007161A (es) | 2021-10-13 |
| US11419880B2 (en) | 2022-08-23 |
| MY203280A (en) | 2024-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11419880B2 (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| US12290497B2 (en) | Agent containing 4-phenylbutyrate, for preventing or treating presbyopia | |
| RU2468793C2 (ru) | Композиции на основе соединений 2-амино-1,3-пропандиола | |
| KR20200084061A (ko) | 안과용 조성물 | |
| JP7597714B2 (ja) | 涙液分泌促進用眼科組成物 | |
| JP6509244B2 (ja) | 水晶体硬化抑制剤 | |
| KR102902220B1 (ko) | 4-페닐부티르산을 함유하는 노시의 치료 또는 예방제 | |
| JP2022152866A (ja) | コール酸またはコール酸誘導体を含有する老視の治療または予防剤 | |
| HK40056566A (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| HK40054770A (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| JP2020514347A (ja) | チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤 | |
| CN116897046A (zh) | 含有熊去氧胆酸或其盐的水性医药组合物 | |
| KR960013437B1 (ko) | 산화형 글루타티온 점안제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |